The mechanisms of calicivirus attachment and internalization are not well understood, mainly due to the lack of a reliable cell-culture system for most of its members. In this study, rabbit vesivirus (RaV) virions were shown to bind annexin A2 (ANXA2) in a membrane protein fraction from HEK293T cells, using a virus overlay protein-binding assay and matrix-assisted laser desorption/ ionization time-of-flight analysis. A monoclonal anti-ANXA2 antibody and small interfering RNAmediated knockdown of ANXA2 expression in HEK293T cells reduced virus infection significantly, further supporting the role of ANXA2 in RaV attachment and/or internalization.
INTRODUCTION
Caliciviruses are relevant pathogens in both veterinary and human medicine against which antiviral strategies are sorely lacking. These viruses cause a wide variety of diseases and symptoms, such as gastroenteritis, vesicular lesions, respiratory infections, reproductive failure and haemorrhagic disease (Green et al., 2000; Hoover & Kahn, 1975; Morens et al., 1979; Thiel & Konig, 1999) . The family Caliciviridae comprises non-enveloped virions of 35 nm in diameter, with a single-stranded, positive-sense RNA genome of 7.4-8.3 kb (Kapikian et al., 1996) . This family has four accepted genera, Lagovirus, Norovirus, Sapovirus and Vesivirus (Green et al., 2000) , and two putative novel genera, Becovirus (Oliver et al., 2006) and Recovirus (Farkas et al., 2008) , which have recently been proposed.
Studies on the replication of most caliciviruses have been hampered severely by the lack of a reliable cell-culture system. More recently, cell-culture systems have been developed for some caliciviruses such as porcine enteric calicivirus (Parwani et al., 1991) , murine norovirus 1 (Wobus et al., 2004) and human noroviruses (Straub et al., 2007) . Human noroviruses can also be recovered from cell cultures using reverse genetics approaches (Asanaka et al., 2005; Guix et al., 2007) . In contrast, most of the members of the genus Vesivirus can be propagated readily in cell culture. Rabbit vesivirus (RaV) has been characterized in our laboratory as a putative novel member of the genus Vesivirus. RaV was isolated from young rabbits (Oryctolagus cuniculus) showing signs of diarrhoea and was grown in cell culture (Martín-Alonso et al., 2005) .
Viral infection usually starts with the binding of virus particles to specific receptor molecules on the host-cell surface. Several cellular factors have been shown to be critical in calicivirus entry, including a2,6-linked sialic acid present on N-linked glycoproteins (Stuart & Brown, 2007) and ABH histo-blood group antigens (Hutson et al., 2002; Marionneau et al., 2002) . In addition, feline functional adhesion molecule 1 (fJAM-1) was recently identified as a functional receptor for feline calicivirus (FCV) (Makino et al., 2006) .
In this study, we developed a virus overlay protein-binding assay (VOPBA) in an attempt to identify cell-surface proteins that interact with RaV and which might be involved in virus attachment and/or penetration. The VOPBA technique has been used to identify several virus receptors, including those for adenoviruses, arenaviruses and coronaviruses (Borrow & Oldstone, 1992; Cao et al., 1998; Dveksler et al., 1991; Oh et al., 2003; Trauger et al., 2004; Wu et al., 2001) , thus supporting the validity of this technique as a first approach to virus receptor investigation.
METHODS
Virus and cells. RaV (Martín-Alonso et al., 2005) was propagated using the human kidney cell line HEK293T cultured in Dulbecco's modified Eagle's minimal essential medium (DMEM) supplemented with 10 % fetal bovine serum (FBS). Virus titration was performed in African green monkey kidney (Vero) cells (ECACC 84113001) using the end-point dilution method (Reed & Muench, 1938) . Vero cells were propagated in DMEM supplemented with 10 % FBS and gentamicin (0.04 mg ml 21 ).
Preparation of cell and membrane extracts. HEK293T cell monolayers in 150 cm 2 flasks were harvested by scraping with a rubber policeman and homogenized with a Dounce homogenizer in hypotonic homogenization buffer containing 25 mM HEPES (pH 7.4), 4 mM EDTA, 250 mM sucrose and a protease inhibitor cocktail (Roche Diagnostics). Intact cells and nuclei in the resulting extract were sedimented by centrifugation at 4 uC for 5 min at 6000 g (Allegra 64R Centrifuge, Beckman Coulter). The membranes were sedimented from the supernatant by a further spin at 20 000 g for 1 h at 4 uC and resuspended in homogenization buffer. Protein concentration was measured by the Bradford assay using BSA as a standard. All extracts were stored at 220 uC until use.
SDS-PAGE and protein electrotransfer. Samples were separated by SDS-PAGE using 10 % polyacrylamide gels run at a constant 120 V (MiniProtean 3; Bio-Rad). A Semi-Phor TE70 apparatus (Hoefer Scientific Instruments) was used to electrotransfer proteins to nitrocellulose membranes at 160 mA for 1 h in transfer buffer VOPBA. The nitrocellulose filters with the transferred proteins were blocked by rocking for 1 h in Tris-buffered saline (TBS) containing 1 % skimmed milk and rinsed three times in TBS. The filters were then incubated overnight with RaV virions (10 10 p.f.u. ml 21 ) diluted 1 : 5 in TBS containing 1 % skimmed milk. After washing with TBS containing 0.1 % Tween, the filters were incubated for 2 h at room temperature with a rabbit anti-mCap polyclonal serum (Casais et al., 2008) diluted in TBS containing 1 % skimmed milk. The blots were then washed with TBS, incubated with protein A peroxidase and the reactive protein bands were visualized by chemiluminescence (Pierce ECL Western Blotting Substrate).
In-gel digestion protein and analysis matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF). Protein bands were excised manually and digested automatically using a Proteineer DP protein digestion station (Bruker-Daltonics). The digestion protocol used was that of Shevchenko et al. (2006) with minor variations: gel plugs were reduced with 10 mM dithiothreitol (Amersham Biosciences) in 50 mM ammonium bicarbonate (99.5 % purity; Sigma Chemical Co.) and alkylated with 55 mM iodoacetamide (Sigma Chemical Co.) in 50 mM ammonium bicarbonate. MALDI mass spectrometry (MS) or MS/MS data were obtained in an automated analysis loop using an Ultraflex TOF mass spectrometer (Bruker-Daltonics) equipped with a LIFT-MS/MS device (Suckau et al., 2003) . Spectra were acquired in the positive-ion mode at 50 Hz laser frequency, and 100-1000 individual spectra were averaged. For fragment ion analysis in the TOF/TOF mode, precursors were accelerated to 8 kV and selected in a timed ion gate. Fragment ions generated by laser-induced decomposition of the precursor were further accelerated by 19 kV in the LIFT cell and their masses were analysed after passing the ion reflector. Automated analysis of mass data were performed using FlexAnalysis software (Bruker-Daltonics). MALDI-MS and MS/MS data were combined through the BioTools program (Bruker-Daltonics) to search a nonredundant protein database (NCBInr: approx. 4.8610 6 entries, National Center for Biotechnology Information; or Swiss-Prot: approx. 2.6610 5 entries, Swiss Institute for Bioinformatics) using Mascot software (Matrix Science). MALDI-MS(/MS) spectra and database search results were inspected manually in detail using the above programs as well as using software produced in house (Perkins et al., 1999) .
Growth curve of RaV in HEK293T cell line. Confluent monolayers in 24-well plates (2.5610 5 cells per well) were incubated with virus at an m.o.i. of 1 for 1 h at 4 uC. After washing with PBS, 1 ml serumfree DMEM was added to each well of cells and incubated at 37 uC in a CO 2 incubator for 0, 2, 4, 8, 12, 20, 24, 33 and 48 h. At each time point, the supernatants from two wells were collected and stored at 280 uC for virus titration. Viral titres were determined by an endpoint dilution assay (TCID 50 ) in Vero cells.
Immunofluorescence assay. Anti-ANXA2 monoclonal antibody (mAb) and fluorescein isothiocyanate-conjugated goat anti-mouse IgG polyclonal antibodies were obtained from Santa Cruz Biotechnology. Immunofluorescence studies were performed on HEK293T cells grown on polylysine glass slides (Lab-Tek II-CC2; Nunc). Cells were fixed in 4 % paraformaldehyde for 20 min and permeabilized for 15 min at room temperature in PBS containing 0.1 % Triton X-100. Cells were washed with PBS and blocked for 45 min in PBS containing 1 % BSA and 0.1 % Triton X-100. Incubations with anti-ANXA2 antibody diluted 1 : 75 were performed overnight in PBS containing 1 % BSA. The secondary antibody was diluted 1 : 100 in PBS containing 1 % BSA and incubated for 1 h at room temperature. Monolayers were washed and mounted with mounting medium (Sigma). Images were acquired using an Olympus DP-70 camera installed on an Olympus BX61 fluorescence microscope.
Inhibition of virus infectivity by anti-ANXA2. Anti-ANXA2 (3D5), anti-ANXA1 (N19) and anti-Claudin-1 (C18) mAbs (200 mg ml 21 ) were purchased from Santa Cruz Biotechnology. HEK293T monolayers at 75 % confluence were incubated for 1 h at 37 uC in a 5 % CO 2 atmosphere with serial dilutions of the relevant antibody (1 : 5 to 1 : 50) using three wells per dilution. The cells were washed with PBS and incubated with RaV at an m.o.i. of 0.01 for 60 min at 37 uC. The cells were washed three times and further incubated in maintenance medium (DMEM containing gentamicin) for 8 h at 37 uC, 5 % CO 2 . The supernatants were removed and stored at 280 uC until virus titration by TCID 50 assay on Vero cell monolayers.
RNA interference assays. HEK293T cells were transfected with 2 mM ON-TARGETplus Smartpool small interfering RNAs (siRNAs) (Dharmacon) directed against annexin A2 (ANXA2) or non-specific Smartpool control siRNA using the siRNA transfection protocol for DharmaFECT 1 (Dharmacon). After 72 h, cells were infected with RaV (m.o.i. of 0.01) and samples were collected at 24 h post-infection (p.i.) for gene-expression studies.
Quantitative RT-PCR. Total RNA was isolated from HEK293T cells using an RNeasy RNA purification kit (Qiagen), including DNase treatment. The integrity of the eluted total RNA was checked by agarose gel electrophoresis and the RNA concentration was determined spectrophotometrically. First-strand cDNA was made using a High Capacity cDNA Reverse Transcription kit (Applied Biosystems) following the manufacturer's instructions. The reverse transcription step was carried out using the following program: 25 uC for 10 min, 37 uC for 120 min and 85 uC for 5 s. Expression levels of ANXA2, ANXA5 and b-actin were assessed by real-time PCR using an ABI Prism 7900 HT thermocycler (Applied Biosystems) and a Fast SYBR Green Master Mix (Applied Biosystems) with the following cycling conditions: 95 uC for 20 s and 40 cycles of 95 uC for 1 s and 60 uC for 20 s. The primers used were 59-CTCTACACCCCCAA-GTGCAT-39 (forward) and 59-TCAGTGCTGATGCAAGTTCC-39 (reverse) for ANXA2; 59-CTGCCTACCTTGCAGAGACC-39 (forward) and 59-CTTCCCCGTGACACGTTAGT-39 (reverse) for ANXA5, and 59-TATCCAGGCTGTGCTATCCCTGTAC-39 (forward) and 59-CTTGATGAGGTAGTCAGTCAGGTCC-39 (reverse) for bactin. The PCR products were separated on 2 % agarose gels containing ethidium bromide (0.5 mg ml 21 ).
RESULTS

Identification of ANXA2 as an RaV-binding protein
In order to search for potential RaV receptors, we used HEK293T cells, a human cell line that allows the use of genomic and proteomic-based tools for identification of putative virus ligands. The virus grew well in this cell line (Fig. 1) and the viral titres remained high after successive virus passages. After virus infection, a lag period of approximately 4 h was observed, followed by an exponential-growth phase that lasted at least 4 h (Fig. 1) . The viral titres increased again between 12 and 33 h p.i., possibly reflecting new rounds of infection. After demonstrating that HEK293T cells were able to support RaV infection and proliferation, semi-purified cell-membrane preparations were obtained from uninfected HEK293T cells, analysed using SDS-PAGE, transferred onto nitrocellulose membranes and subsequently used in VOPBAs. The data obtained indicated that RaV virions attached to several components of HEK293T membranes, revealing five major protein products of 25, 30, 33, 80 and 90 kDa (Fig. 2, lane  2) . The antiserum used to detect RaV virions in VOPBA assays did not react with any of these protein bands when added directly to the filters without previous exposure to RaV virions (Fig. 2, lane 1) , thus indicating that the VOPBA results were the consequence of RaV attachment onto defined polypeptide components of HEK293T membranes. Gel slices containing the reacting proteins were digested with trypsin and the resulting peptides were subjected to MS analysis. The peptide mass fingerprints were then used to search the databases in order to identify the corresponding proteins (Blackstock & Weir, 1999; Yates, 2000) . Mass lists were submitted for a search against the NCBI protein database using the Mascot search engine (Perkins Engines) . The reacting bands with molecular masses of 90, 80, 30 and 25 kDa could not be identified by MS analysis. In contrast, the sample containing the 33 kDa reacting protein was characterized as ANXA2 (see Supplementary Fig. S1 , available in JGV Online). To corroborate the VOPBA results further and to validate the MS data, we first analysed similar membrane protein extracts from HEK293T cells using VOPBA by preincubating with an anti-ANXA2 mAb prior to incubation with RaV virions. The VOPBA results obtained after anti-ANXA2 mAb 3D5 incubation showed that the 33 kDa protein band could not be detected (Fig. 2, lane 3) , suggesting that the interaction between the virus and the 33 kDa protein band was specifically inhibited by the 3D5 antibody. The specificity of this reaction was also supported by the results obtained in a parallel Western blot analysis using mAb 3D5 (Fig. 2, lane 4) , which reacted specifically with a 33 kDa protein present in the HEK293T membrane fraction. An immunofluorescence analysis of HEK293T cells using mAb 3D5 also showed that this protein was located on the surface of the cells (Fig. 2b) , thus supporting its accessibility to the virions in intact cells.
Inhibition of virus infectivity by an anti-ANXA2 antibody
To investigate the biological relevance of ANXA2 in RaV cell attachment or in subsequent virus entry, HEK293T cell cultures were treated for 1 h with different concentrations of anti-ANXA2 mAb 3D5 or with control mAbs anti-ANXA1 (N19) or anti-Claudin-1 (C18). After treatment, the cultures were infected with RaV at an m.o.i. of 0.01 and incubated for 8 h in order to explore the effects of anti-ANXA2 treatment on the initial exponential phase (Fig. 1) of the RaV growth curve. The treated and untreated cultures were collected for virus titration on Vero cells (Fig. 3) . The virus yields of untreated cultures at 8 h p.i. were 10 5.1 -10 5.5 p.f.u. ml 21 . The cultures treated with control mAbs N19 and C18 (Fig. 3, shaded and open bars) did not show significant viral titre decreases with respect to untreated controls, even when they were used at high concentrations. In contrast, anti-ANXA2 antibody-treated cultures significantly decreased RaV titres depending on the antibody dilution used (Fig. 3, filled bars) . It was observed that 40 mg mAb 3D5 ml 21 gave rise to a reduction in virus yield of 1.4 logs (viral titre 10 3.7 p.f.u. ml 21 ), which indicated a 96 % inhibition of viral infectivity in HEK293T cells. Lower antibody concentrations produced smaller reductions in the viral titres (Fig. 3) . Treatment with 20 mg mAb 3D5 ml 21 led to a viral titre of 10 3.85 p.f.u. ml 21 (94.4 % inhibition), the use of 10 mg ml 21 gave a titre of 10 4.53 p.f.u. ml 21 (73 % inhibition) and 4 mg anti-ANXA2 mAb 3D5 ml 21 reduced the viral titre to 10 4.72 p.f.u. ml 21 (58.3 % of untreated control). It should be noted that none of the antibody treatments used reduced cell viability.
ANXA2 expression knockdown
To test further the relevance of ANXA2 in RaV replication, we examined viral production in HEK293T cells whose ANXA2 expression had been strongly decreased using a siRNA method. HEK293T cells were treated with an ANXA2-specific siRNA (siANXA2) or a non-targeting siRNA (nt-RNA) as a control for non-sequence-specific effects. Changes in mRNA or protein levels in cells treated with this control RNA reflected a non-specific baseline cellular response to which the levels in cells treated with target-specific siRNA could be compared. The RT-PCR data obtained indicated that siANXA2 decreased the levels of ANXA2 expression beginning 48 h after transfection, a reduction that was not seen in cells treated with nt-RNA. The siANXA2 treatment did not modify ANXA5 (Fig. 4) or b-actin (not shown) expression levels. Quantitative PCR demonstrated a significant and specific reduction in ANXA2 RNA levels in siANXA2-treated cultures (Fig. 4 ) compared with control cultures (untreated and nt-RNAtreated cells). Transfection with siANXA2 or nt-RNA did not change the expression of ANXA5, a member of the annexin family, nor did it affect that of b-actin (not shown) whose expression levels were similar in the three treatment groups (Fig. 4) . It should be noted that none of the RNA treatments produced significant effects on cell viability. In order to evaluate the biological consequences of ANXA2 knockdown with regard to RaV infection and proliferation, 48 h after siRNA treatment, transfected and control HEK293T cultures were infected with RaV at an m.o.i. of 0.01 and the cultures were collected at 8 h p.i. for virus titration on Vero cells. The results indicated that siANXA2 treatment diminished viral titres from 10 4.5 p.f.u. ml 21 in the untreated control to 10 2.95 p.f.u. ml 21 (Fig. 5 ), thus producing a 97.2 % reduction in virus yield with respect to the untreated control. The non-targeting siRNA did not have a significant effect on viral titres (Fig. 5 ). These data further confirmed the direct role of ANXA2 in RaV infectivity.
DISCUSSION
The investigation of early events in the infection of susceptible cells by caliciviruses is important to help understand the ability of this group of viruses to produce acute gastroenteritis in humans, as well as respiratory illness, conjunctivitis, stomatitis and haemorrhagic disease in animals Kapikian et al., 1972; Thiel & Konig, 1999) . Determination of the nature of the early interactions of the infecting viruses with molecules on the surface of susceptible cells can lead to the development of therapeutic agents that can be used to inhibit virus infection.
VOPBA was used to identify cell-membrane proteins interacting with the RaV capsid protein. This technique has been used to characterize putative cell receptors for a number of viruses including Sendai virus (Gershoni et al., 1986) , reovirus (Choi et al., 1990; Verdin et al., 1989) , human cytomegalovirus (Adlish et al., 1990; Taylor & Cooper, 1990 ), Theiler's virus (Kilpatrick & Lipton, 1991) and visna virus (Crane et al., 1991) . It was also shown that a receptor for mouse hepatitis virus, identified by VOPBA, was shown to act as the true virus receptor in vitro and in vivo (Dveksler et al., 1991) , confirming this technique as a useful approach for the detection of putative viral receptors.
In this study, several interactions were initially identified, including a 33 kDa protein band subsequently identified as ANXA2. As some positive reactions detected by VOPBA may not necessarily reflect a native interaction on target cells, the biological relevance of this protein was investigated further using both an RNA interference approach and anti-ANXA2 antibodies, with the aim of analysing their putative interference with RaV infection in HEK293T cell cultures. Our data indicated that both treatments led to a significant inhibition (96-97.2 %) in virus yields with respect to untreated control cultures. These data provide the first evidence that ANXA2 is involved in early infection events for rabbit vesivirus, perhaps acting as a functional receptor.
Annexins are a family of conserved proteins characterized by their ability to bind and order charged phospholipids in membranes, often in response to elevated intracellular calcium. The family members (there are at least 12 in humans) are specialized and are involved in a diverse range of cellular functions, both inside the cell and extracellularly (Hayes et al., 2007) . ANXA2 is a calcium-dependent phospholipid-binding protein that also associates with actin filaments and mediates membrane-membrane and membrane-cytoskeletal interactions. The physiological function of ANXA2 is still not clear, possibly because the mechanisms suggested by in vitro experiments are more complex than originally postulated. It plays an important role in membrane trafficking and stabilization of membrane-associated protein complexes with the actin cytoskeleton (Gerke & Moss, 2002; Oliferenko et al., 1999) , a property that might underlie the potential contributions of ANXA2 to endocytic and exocytic pathways (Donato & Russo-Marie, 1999) . Data obtained with biological membranes and liposomes have shown that ANXA2 is able to facilitate membrane fusion (Raynor et al., 1999) . It has also been shown that ANXA2 is upregulated in migrating intestinal epithelial cells (Babbin et al., 2007) . In addition, the role of ANXA2 has been examined in connection with several viruses. A number of studies have suggested that the anionic phospholipid-binding protein ANXA2 may play a role in human cytomegalovirus (HCMV) infection, providing the first direct evidence that ANXA2 has the capacity to bridge HCMV to a phospholipid membrane and to enhance virus-membrane fusion (Raynor et al., 1999) . ANXA2 has also been shown to be a receptor for respiratory syncytial virus in epithelial cells (Malhotra et al., 2003) . Similarly, other annexins such as ANXA5 are involved in influenza virus entry (Otto et al., 1994) .
In this report, we have provided the first evidence of the potential role of ANXA2 in calicivirus infection. Previous studies have highlighted the importance of the interactions of some caliciviruses with cell-surface glycans (Harrington et al., 2002; Marionneau et al., 2002; Stuart & Brown, 2007) , a2,6-sialic acid in the case of FCV and histo-blood group antigens in the case of the norovirus and rabbit hemorrhagic disease virus. Subsequent diffusion or trafficking of bound virions across the cell surface may then lead to their entry after interactions with specific protein receptors such as JAM-1 located in tight junctions (Bhella et al., 2008) .
Here, we have shown profound inhibitory effects on RaV infection of HEK293T cells by interfering with ANXA2 binding using specific antibodies or by lowering ANXA2 expression levels, although the virus resistance of treated HEK293T cells was not complete. This could suggest that some additional factors might be involved in virus entry, or may simply reflect the incomplete blocking of ANXA2 binding using antibodies or the existence of residual receptor levels after siRNA treatment.
As RaV was initially isolated from rabbits suffering from diarrhoea, it was expected that most tissues related to the gastric system should have virus receptors. Thus, we have preliminarily investigated ANXA2 tissue distribution using VOPBA, which might give clues about putative RaV tissue tropism. The results found (not shown) indicated the presence of a single RaV-reacting band of approximately 33 kDa in different tissues, many of them related to the gastric system. Binding was also observed to a similar-sized protein band in other tissues such as brain, spleen and kidney.
Considering phylogenetic analyses as well as genomic organization, RaV is clearly placed in the marine-related calicivirus branch [together with vesicular exanthema of swine virus and San Miguel sea lion virus (SMSV)] within the genus Vesivirus, which is separate from that including FCV (Martín-Alonso et al., 2005) . It will be interesting to investigate whether other members of this group, such as SMSV, also use ANXA2 in cell entry.
The findings reported here give a first insight into RaV cellentry mechanisms.
